Advertisement

A fatal case of pneumonia caused by Thermothelomyces thermophila

Published:September 27, 2022DOI:https://doi.org/10.1016/j.jiac.2022.09.015

      Abstract

      Thermothelomyces thermophila (formerly Myceliophthora thermophila) is usually found in soil and specifically compost as an environmental dematiaceous fungus. Here, we report the first case of invasive pulmonary infection caused by T. thermophila in a pediatric patient with acute lymphoblastic leukemia. T. thermophila was serially cultured from bronchoalveolar lavage (BAL) fluid and sputum samples obtained from this patient with respiratory symptoms. The patient received antifungal treatment with liposomal amphotericin B (160 mg daily) and itraconazole (200 mg daily) combination therapy, but she died. By the antifungal susceptibility testing, low minimum inhibitory concentrations (MIC) were observed for itraconazole (MIC 0.06 μg/mL), voriconazole (MIC 0.12 μg/mL), and posaconazole (MIC 0.03 μg/mL) but high MIC was observed with amphotericin B (MIC 4.0 μg/mL). Since T. thermophila is usually found in the environment, it can be considered as a contaminant and may cause difficulties in diagnosis. Therefore, it is necessary to confirm the potential of pathogen through repeated culture and to conduct an antifungal susceptibility testing to find a suitable antifungal agent.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Journal of Infection and Chemotherapy
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Young A.Y.
        • Leiva Juarez M.M.
        • Evans S.E.
        Fungal pneumonia in patients with hematologic malignancy and hematopoietic stem cell transplantation.
        Clin Chest Med. 2017; 38: 479-491https://doi.org/10.1016/j.ccm.2017.04.009
        • Eren E.
        • Alp E.
        • Cevahir F.
        • Tok T.
        • Kılıç A.U.
        • Kaynar L.
        • et al.
        The outcome of fungal pneumonia with hematological cancer.
        Infect Chemother. 2020; 52: 530-538https://doi.org/10.3947/ic.2020.52.4.530
        • Morio F.
        • Fraissinet F.
        • Gastinne T.
        • Pape P.L.
        • Delaunay J.
        • Sigler L.
        • et al.
        Invasive Myceliophthora thermophila infection mimicking invasive aspergillosis in a neutropenic patient: a new cause of cross-reactivity with the Aspergillus galactomannan serum antigen assay.
        Med Mycol. 2011; 49: 883-886https://doi.org/10.3109/13693786.2011.584218 %J Medical Mycology
        • Le Naourès C.
        • Bonhomme J.
        • Terzi N.
        • Duhamel C.
        • Galateau-Sallé F.
        A fatal case with disseminated Myceliophthora thermophila infection in a lymphoma patient.
        Diagn Microbiol Infect Dis. 2011; 70: 267-269https://doi.org/10.1016/j.diagmicrobio.2011.01.003
        • Nourrisson C.
        • Garcia-Hermoso D.
        • Morio F.
        • Kauffmann-Lacroix C.
        • Berrette N.
        • Bonhomme J.
        • et al.
        Thermothelomyces thermophila human infections.
        Clin Microbiol Infect. 2017; 23: 338-341https://doi.org/10.1016/j.cmi.2016.10.025
        • Bourbeau P.
        • McGough D.A.
        • Fraser H.
        • Shah N.
        • Rinaldi M.G.
        Fatal disseminated infection caused by Myceliophthora thermophila, a new agent of mycosis: case history and laboratory characteristics.
        J Clin Microbiol. 1992; 30: 3019-3023https://doi.org/10.1128/jcm.30.11.3019-3023.1992
        • Donnelly J.P.
        • Chen S.C.
        • Kauffman C.A.
        • Steinbach W.J.
        • Baddley J.W.
        • Verweij P.E.
        • et al.
        Revision and update of the consensus definitions of invasive fungal disease from the European organization for research and treatment of cancer and the mycoses study group education and research consortium.
        Clin Infect Dis. 2019; 71: 1367-1376https://doi.org/10.1093/cid/ciz1008 %J Clinical Infectious Diseases
        • CLSI
        CLSI guideline MM18.
        second ed. Clinical and Laboratory Standards Institute, Wayne, PA2018 (Interpretive criteria for identification of bacteria and fungi by targeted DNA sequencing)
        • CLSI
        Reference method for broth dilution antifungal susceptibility testing of filamentous fungi; approved standard.
        in: CLSI document M38-A2. second ed. Clinical and Laboratory Standards Institute, Wayne, PA2008
        • Ben-Ami R.
        • LaSala P.R.
        • Lewis R.E.
        • Kontoyiannis D.P.
        Lack of galactomannan reactivity in dematiaceous molds recovered from cancer patients with phaeohyphomycosis.
        Diagn Microbiol Infect Dis. 2010; 66: 200-203https://doi.org/10.1016/j.diagmicrobio.2009.09.015
        • Liao H.
        • Zhang Y.
        • Guo W.
        • Wang X.
        • Wang H.
        • Ye H.
        • et al.
        Characterization of the blood and cerebrospinal fluid microbiome in children with bacterial meningitis and its potential correlation with inflammation.
        mSystems. 2021; 6 (e): e0004921https://doi.org/10.1128/mSystems.00049-21